GRFS

#4977
Grifois, S.A.
9.10
-0.22%
Setor:
Base:
Moeda do lucro:
Faixa diária
9.10
9.10
Faixa anual
6.19
11.14
Mudança diária
-0.22%
Mudança mensal
-1.83%
Mudança em 6 meses
-7.89%
Mudança anual
+12.48%
Fechamento anterior
9.12
Open
9.10
Bid
Ask
Low
9.10
High
9.10
Volume
15
Open full chart

Financials

Overview Relatórios Statistics Dividends
Quarterly Annual
  • Market Capitalization N/A
  • Employee 24 K
  • Founded N/A
  • CEO Nacho Abia
  • Website www.grifols.com
  • Headquarter New York, United States
  • FIGI BBG001QMCKF6
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
—
Price to sales ratio
—
Dividends per share
—
Dividend yield %
—

Grifols, S.A. - American Depositary Shares

Grifols, S.A. is a global healthcare company and leading producer of plasma-derived medicines founded in Barcelona, Catalonia, Spain, in 1909. With a workforce of over 23,800 employees, Grifols serves more than 110 countries and regions and maintains a direct presence in over than 30. Principally a producer of blood plasma–based products and other biopharmaceuticals, the company also operates in transfusion medicine, supplying devices, instruments and reagents for clinical testing laboratories, as well as clinical diagnostic technologies. Furthermore, it provides biological supplies for life-science research, clinical trials and the manufacturing of pharmaceutical and diagnostic products. It has a portfolio on four therapeutic areas: immunology, infectious diseases, pulmonology and critical care.

Notícias